Giulia Boccalini

Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

Cristina Guarducci, Martina Bonechi, Matteo Benelli et al. · npj Breast Cancer · 2018 · 135 citations · Full text

Medicine, Oncology, Pharmacology +17

Methylene blue-containing liposomes as new photodynamic anti-bacterial agents

Giulia Boccalini, Luca Conti, Costanza Montis et al. · Journal of Materials Chemistry B · 2017 · 68 citations · Full text

Pharmacy, Microbiology, Pharmacology +17

Relaxin protects cardiac muscle cells from hypoxia/reoxygenation injury: involvement of the Notch‐1 pathway

Giulia Boccalini, Chiara Sassoli, Lucia Formigli et al. · The FASEB Journal · 2014 · 67 citations · Full text

Medicine, Cardiology, Pharmacology +15

<scp>HYDAMTIQ</scp>, a selective <scp>PARP</scp>‐1 inhibitor, improves bleomycin‐induced lung fibrosis by dampening the <scp>TGF</scp>‐β/<scp>SMAD</scp> signalling pathway

Laura Lucarini, Mariaconcetta Durante, Cecilia Lanzi et al. · Journal of Cellular and Molecular Medicine · 2016 · 58 citations · Full text

Life Sciences, Molecular Biology, Pathobiology +15

Plasma thymidine kinase-1 activity predicts outcome in patients with hormone receptor positive and HER2 negative metastatic breast cancer treated with endocrine therapy

Martina Bonechi, Francesca Galardi, Chiara Biagioni et al. · Oncotarget · 2018 · 54 citations · Full text

Medicine, Endocrinology, Oncology +17